PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
11-Beta-Hydroxylase		Target	Disease	Asthma
11-Beta-Hydroxylase		Target	Disease	Inflammation
11-Beta-Hydroxylase		Target	Disease	Heart Disease
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Drug	Doxazosin
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	AKT2
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Ovarian Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Anxiety
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	AKT3
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Viral Disease
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Lung Carcinoma
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	ANGPTL4
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	Phospholipase A2
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Diabetic Nephropathy
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	Calcium Dependent Atpase
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Cholesterol
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Testicular Cancer
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Familial Adenomatous Polyposis
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Target	ADRP
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Drug	Doxorubicin
3-Phosphoinositide-Dependent Protein Kinase 1		Target	Disease	Mesothelioma
4-1BB Ligand		Target	Disease	Multiple Myeloma
4-1BB Ligand		Target	Disease	Organ Transplantation
4-1BB Ligand		Target	Disease	Arthritis
4-1BB Ligand		Target	Disease	Chronic Lymphocytic Leukemia
4-1BB Ligand		Target	Disease	Rheumatoid Arthritis
4-1BB Ligand		Target	Target	Collagen
4-1BB Ligand		Target	Disease	Leukemias
4-1BB Ligand		Target	Target	CCL3
4-1BB Ligand		Target	Disease	Myelodysplastic Syndrome
4-1BB Ligand		Target	Disease	Sepsis
4-1BB Ligand		Target	Target	BTK
4-1BB Ligand		Target	Disease	Breast Cancer
4-1BB Ligand		Target	Disease	Asthma
4-1BB Ligand		Target	Drug	Doxorubicin
4-1BB Receptor		Target	Disease	Conjunctivitis
4-1BB Receptor		Target	Disease	Tuberculosis
4-1BB Receptor		Target	Disease	Lung Carcinoma
4-1BB Receptor		Target	Disease	Influenza
4-1BB Receptor		Target	Disease	Shock
4-1BB Receptor		Target	Target	Collagen
4-1BB Receptor		Target	Disease	Leukemia
4-1BB Receptor		Target	Disease	Inflammation
4-Mercaptobenzoic Acid		Drug	Disease	Malaria
4-Mercaptopyridine		Drug	Disease	Cancer
4-Mercaptopyridine		Drug	Drug	Doxorubicin
4-Mercaptopyridine		Drug	Disease	Glioblastoma
464.1		Target	Disease	Hypotension
464.1		Target	Disease	Cholesterol
464.1		Target	Disease	Leukemia
464.1		Target	Disease	Asthma
464.1		Target	Disease	Inflammation
5-Hydroxytryptamine 2a Receptor		Target	Target	Collagen
5-Hydroxytryptamine 2a Receptor		Target	Target	Sphingomyelinase
5-Hydroxytryptamine 2a Receptor		Target	Target	EGF
5-Hydroxytryptamine 2a Receptor		Target	Disease	Mania
5-Hydroxytryptamine 2a Receptor		Target	Disease	Psoriasis
5-Hydroxytryptamine 2a Receptor		Target	Disease	Autism
5-Hydroxytryptamine 2a Receptor		Target	Target	BDNF
5-Hydroxytryptamine 2a Receptor		Target	Disease	Seizures
5-Hydroxytryptamine 2a Receptor		Target	Disease	Inflammation
5-Hydroxytryptamine 2b Receptor		Target	Disease	Central Nervous System Diseases
5-Hydroxytryptamine 2b Receptor		Target	Disease	Obesity
5-Hydroxytryptamine 2b Receptor		Target	Target	ERK1
5-Hydroxytryptamine 2b Receptor		Target	Target	5-Hydroxytryptamine 2a Receptor
5-Hydroxytryptamine 2b Receptor		Target	Disease	Migraine
5-Hydroxytryptamine 2b Receptor		Target	Disease	Amyotrophic Lateral Sclerosis
5-Hydroxytryptamine 2b Receptor		Target	Target	D(2) Dopamine Receptor
5-Hydroxytryptamine 2b Receptor		Target	Target	Elastase
5-Hydroxytryptamine 2b Receptor		Target	Disease	Liver Disease
744.1		Target	Disease	Carcinoma
744.1		Target	Disease	Acute Promyelocytic Leukemia
744.1		Target	Disease	Chronic Obstructive Pulmonary Disease
744.1		Target	Disease	Stroke
744.1		Target	Target	Adiponectin
744.1		Target	Target	464.1
744.1		Target	Disease	Hepatitis
744.1		Target	Disease	Dyslipidemia
744.1		Target	Disease	Leukemia
744.1		Target	Disease	Liver Disease
A-Methapred (Methylprednisolone Sodium Succinate)- FDA		Drug	Drug	Adalimumab (Humira)- FDA
A1AT		Target	Disease	Renal Failure
A1AT		Target	Disease	Anemia
A1AT		Target	Target	APOA1
A1AT		Target	Disease	Respiratory Tract Infections
A1AT		Target	Target	APOA2
A1AT		Target	Disease	Acute Coronary Syndromes
A1AT		Target	Target	CER
A1AT		Target	Target	Alpha-Amylase
A1AT		Target	Target	CD95
A1AT		Target	Disease	Menopause
A1AT		Target	Disease	Ileus
A1AT		Target	Target	Proteinase-Activated Receptor 1
A1AT		Target	Target	EGF
A1AT		Target	Disease	Rare Diseases
A1AT		Target	Target	CALR
A1AT		Target	Disease	Down Syndrome
A1AT		Target	Disease	Bacterial Infections
A1AT		Target	Disease	Proteinuria
A1AT		Target	Target	CD34
A1AT		Target	Disease	Ankylosing Spondylitis